Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar-Apr;17(2):125-133.
doi: 10.5055/jom.2021.0623.

Opioid prescription claims among women aged 15-44 years-United States, 2013-2017

Affiliations

Opioid prescription claims among women aged 15-44 years-United States, 2013-2017

April D Summers et al. J Opioid Manag. 2021 Mar-Apr.

Abstract

Objective: To estimate the annual percentage of women of reproductive age with private insurance or Medicaid who had opioid prescription claims during 2013-2017 and describe trends over time.

Design: A secondary analysis of insurance claims data from IBM MarketScan® Commercial and Multi-State Medicaid Databases to assess outpatient pharmacy claims for prescription opioids among women aged 15-44 years during 2013-2017.

Participants: Annual cohorts of 3.5-3.8 million women aged 15-44 years with private insurance and 0.9-2.1 million women enrolled in Medicaid.

Main outcome measure: The percentage of women aged 15-44 years with outpatient pharmacy claims for opioid prescriptions.

Results: During 2013-2017, the proportion of women aged 15-44 years with private insurance who had claims for opioid prescriptions decreased by 22.1 percent, and among women enrolled in Medicaid, the proportion decreased by 31.5 -percent.

Conclusions: Opioid prescription claims decreased from 2013 to 2017 among insured women of reproductive age. However, opioid prescription claims remained common and were more common among women enrolled in Medicaid than those with private insurance; additional strategies to improve awareness of the risks associated with opioid prescribing may be needed.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors have no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.. Percentage* of women and men aged 15–44 years with private or Medicaid insurance who filled a prescription for an opioid from an outpatient pharmacy, by insurance type and year—United States, 2013–2017.
*The percentage of individuals with opioid prescription claims was calculated among the total population of eligible women or men, eg, women aged 15–44 years enrolled ≥334 days per year in a plan that includes prescription drug coverage. The same individual could be included in more than one year of data.
Figure 2.
Figure 2.. Percentage* of women aged 15–44 years with private or Medicaid insurance who filled more than one opioid prescription, among those who filled at least one opioid prescription, by year—United States, 2013–2017.
*The percentage of women who filled more than one opioid prescription was calculated among the population of eligible women who filled at least one opioid prescription, ie, women aged 15–44 years enrolled ≥334 days per year in a plan that includes prescription drug coverage. The same woman could be included in more than one year of data.

References

    1. Maeda A, Bateman BT, Clancy CR, et al.: Opioid abuse and dependence during pregnancy: Temporal trends and obstetrical outcomes. Anesthesiology. 2014; 121(6): 1158–1165. - PubMed
    1. Desai RJ, Huybrechts KF, Hemandez-Diaz S, et al.: Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: Population based cohort study. BMJ. 2015; 350: h2102. - PMC - PubMed
    1. Lind JN, Interrante JD, Ailes EC, et al.: Maternal use of opioids during pregnancy and congenital malformations: A systematic review. Pediatrics. 2017;139(6): e20164131. - PMC - PubMed
    1. Fill MA, Miller AM, Wilkinson RH, et al.: Educational disabilities among children born with neonatal abstinence syndrome. Pediatrics. 2018; 142(3): e20180562. - PMC - PubMed
    1. Dowell D, Haegerich TM, Chou R: CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. MMWR Recomm Rep 2016;65(No. RR-1):1–49. - PubMed

Substances

LinkOut - more resources